Open access
Oct 2026
Durvalumab plus etoposide-carboplatin for advanced digestive neuroendocrine carcinoma: a phase III trial (JCOG2107E).
CLINICAL TRIAL REGISTRATION jRCT2031230456 (https://jrct.mhlw.go.jp/latest-detail/jRCT2031230456).
Y. Sano, Y. Maruki, C. Morizane et al.
· Future Oncology · 0 citations